Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-18

Clinical Trial Update: Hypofractionated Radiotherapy [NA]

View source ↗

Summary

A clinical trial evaluating hypofractionated radiotherapy for glioblastoma is currently recruiting, sponsored by The First Hospital of Jilin University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Glioblastoma | NA | Status: RECRUITING